Daniel E. Salazar

5.6k total citations · 1 hit paper
102 papers, 4.2k citations indexed

About

Daniel E. Salazar is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Surgery. According to data from OpenAlex, Daniel E. Salazar has authored 102 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 22 papers in Pharmacology and 19 papers in Surgery. Recurrent topics in Daniel E. Salazar's work include Antiplatelet Therapy and Cardiovascular Diseases (21 papers), Lipoproteins and Cardiovascular Health (12 papers) and Pharmacogenetics and Drug Metabolism (11 papers). Daniel E. Salazar is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (21 papers), Lipoproteins and Cardiovascular Health (12 papers) and Pharmacogenetics and Drug Metabolism (11 papers). Daniel E. Salazar collaborates with scholars based in United States, United Kingdom and Germany. Daniel E. Salazar's co-authors include Kenneth J. Winters, Christopher D. Payne, John T. Brandt, George B. Corcoran, C. Steven Ernest, David S. Small, Nagy A. Farid, Nazar Farid, Joseph A. Jakubowski and Ying G. Li and has published in prestigious journals such as Circulation, The Journal of Immunology and Stroke.

In The Last Decade

Daniel E. Salazar

99 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel

2007 553 citations John T. Brandt, Sandra Close et al. Journal of Thrombosis and Haemostasis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel E. Salazar United States	32	2.3k	910	687	677	555	102	4.2k
Dietmar Trenk Germany	31	4.4k 1.9×	2.2k 2.4×	562 0.8×	1.1k 1.7×	562 1.0×	161	5.3k
Renke Maas Germany	47	2.9k 1.3×	670 0.7×	302 0.4×	65 0.1×	605 1.1×	156	6.7k
Jessica L. Mega United States	32	6.6k 2.9×	3.4k 3.7×	970 1.4×	1.8k 2.7×	1.4k 2.5×	80	13.2k
Patrizia Ferroni Italy	41	1.1k 0.5×	734 0.8×	258 0.4×	644 1.0×	393 0.7×	218	5.5k
Hui Quan United States	32	1.2k 0.5×	1.4k 1.6×	3.3k 4.9×	53 0.1×	303 0.5×	111	8.2k
Peter R. Kowey United States	62	11.5k 5.0×	1.0k 1.1×	230 0.3×	1.3k 2.0×	686 1.2×	368	13.0k
Philip R. Liebson United States	32	8.4k 3.7×	2.1k 2.3×	194 0.3×	490 0.7×	792 1.4×	96	10.1k
Mia Wadelius Sweden	38	1.4k 0.6×	557 0.6×	804 1.2×	285 0.4×	1.5k 2.6×	101	7.2k
Nancy A. Nussmeier United States	26	2.6k 1.2×	2.4k 2.6×	906 1.3×	156 0.2×	88 0.2×	71	4.5k
James A. Bolognese United States	31	1.1k 0.5×	1.3k 1.5×	3.3k 4.8×	40 0.1×	265 0.5×	71	5.7k

Countries citing papers authored by Daniel E. Salazar

Since Specialization

Citations

This map shows the geographic impact of Daniel E. Salazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Salazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Salazar more than expected).

Fields of papers citing papers by Daniel E. Salazar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Salazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Salazar. The network helps show where Daniel E. Salazar may publish in the future.

Co-authorship network of co-authors of Daniel E. Salazar

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Salazar. A scholar is included among the top collaborators of Daniel E. Salazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Salazar. Daniel E. Salazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beharry, James, Daniel E. Salazar, K. A. Smith, et al.. (2021). Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke. Stroke. 52(3). 1087–1090. 65 indexed citations

Salazar, Daniel E., Jingpu Shi, Shashank Rohatagi, et al.. (2011). The Use of Modeling and Simulation to Guide Clinical Development of Olmesartan Medoxomil in Pediatric Subjects. Clinical Pharmacology & Therapeutics. 91(2). 250–256. 8 indexed citations

Rocco, Claudio M., et al.. (2010). ANÁLISIS PRELIMINAR DE LA VULNERABILIDAD DE UN SISTEMA DE POTENCIA MEDIANTE INTERDICCIÓN DETERMINISTA MULTIOBJETIVO. 25(1). 61–69.

Rohatagi, Shashank, et al.. (2010). Correlation of Inhibition of Platelet Aggregation With Cardiovascular and Bleeding Outcomes in Acute Coronary Syndromes. The Journal of Clinical Pharmacology. 50(8). 904–913. 4 indexed citations

Rocco, Claudio M., Daniel E. Salazar, & Enrico Zio. (2009). Application of advanced computational techniques to the vulnerability assessment of network systems exposed to uncertain harmful events. International Journal of Performability Engineering. 5(1). 71–84. 1 indexed citations

Findling, Robert L., Ralph E. Kauffman, Floyd R. Sallee, et al.. (2009). An Open-Label Study of Aripiprazole: Pharmacokinetics, Tolerability, and Effectiveness in Children and Adolescents with Conduct Disorder. Journal of Child and Adolescent Psychopharmacology. 19(4). 431–439. 38 indexed citations

Small, D. S., Rebecca E. Wrishko, C. Steven Ernest, et al.. (2009). Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease. Journal of Clinical Pharmacy and Therapeutics. 34(5). 585–594. 61 indexed citations

Small, David S., Prajakti A. Kothare, Eunice Yuen, et al.. (2009). The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects. European Journal of Clinical Pharmacology. 66(2). 127–135. 55 indexed citations

Wrishko, Rebecca E., C. Steven Ernest, David S. Small, et al.. (2009). Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON‐TIMI 38. The Journal of Clinical Pharmacology. 49(8). 984–998. 66 indexed citations

10.

Rohatagi, Shashank, Helen Kastrissios, Kunihiro Sasahara, et al.. (2008). Pain relief model for a COX‐2 inhibitor in patients with postoperative dental pain. British Journal of Clinical Pharmacology. 66(1). 60–70. 5 indexed citations

11.

Brandt, John T., Sandra Close, Stephen J. Iturria, et al.. (2007). Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel. Journal of Thrombosis and Haemostasis. 5(12). 2429–2436. 553 indexed citations breakdown →

12.

Payne, Christopher D., David S. Small, C. Steven Ernest, et al.. (2007). Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel. Journal of Cardiovascular Pharmacology. 50(5). 555–562. 135 indexed citations

13.

Citrome, Leslie, Jean-Paul Macher, Daniel E. Salazar, Suresh Mallikaarjun, & David W. Boulton. (2007). Pharmacokinetics of Aripiprazole and Concomitant Carbamazepine. Journal of Clinical Psychopharmacology. 27(3). 279–283. 43 indexed citations

14.

Salazar, Daniel E., et al.. (1999). Pharmacokinetic evaluation of co-administration of nefazodone and lithium in healthy subjects. European Journal of Clinical Pharmacology. 54(12). 923–928. 8 indexed citations

15.

Cutler, Neal R., Daniel E. Salazar, Stanford S. Jhee, et al.. (1998). Pharmacokinetics and Pharmacodynamics of Avitriptan in Patients With Migraine After Oral Dosing. Headache The Journal of Head and Face Pain. 38(6). 446–452. 5 indexed citations

16.

Salazar, Daniel E., et al.. (1997). A Pharmacokinetic—Pharmacodynamic Model of d‐Sotalol Q‐Tc Prolongation During Intravenous Administration to Healthy Subjects. The Journal of Clinical Pharmacology. 37(9). 799–809. 15 indexed citations

17.

Greene, Douglas S., Daniel E. Salazar, Randy Dockens, Patricia D. Kroboth, & Rashmi H. Barbhaiya. (1995). Coadministration of Nefazodone and Benzodiazepines. Journal of Clinical Psychopharmacology. 15(6). 409–416. 11 indexed citations

18.

Kroboth, Patricia D., et al.. (1995). Coadministration of Nefazodone and Benzodiazepines. Journal of Clinical Psychopharmacology. 15(5). 306–319. 28 indexed citations

19.

Corcoran, George B., et al.. (1989). Obesity as a risk factor in drug-induced organ injury. Toxicology and Applied Pharmacology. 98(1). 12–24. 16 indexed citations

20.

Corcoran, George B., Daniel E. Salazar, & J J Schentag. (1988). Excessive aminoglycoside nephrotoxicity in obese patients. The American Journal of Medicine. 85. 279–279. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact